Predictors of Extracorporeal Membrane Oxygenation Support for Children with Acute Myocarditis

Han-Ping Wu1,2, Mao-Jen Lin3,4, Wen-Chieh Yang5,6

  • 1Division of Pediatric General Medicine, Department of Pediatrics, Chang Gung Memorial Hospital at Linko, Kweishan, Taoyuan, Taiwan.

Insights

Female sex, vomiting, seizures, and low ejection fraction in children with acute myocarditis may predict the need for extracorporeal membrane oxygenation (ECMO) support.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine

Background:

  • Acute myocarditis in children presents with a wide range of symptoms, from mild to severe, including sudden cardiac arrest.
  • Early identification of children requiring advanced support like extracorporeal membrane oxygenation (ECMO) is crucial for timely intervention.

Purpose of the Study:

  • To analyze the clinical spectrum of acute myocarditis in children.
  • To identify predictors for extracorporeal membrane oxygenation (ECMO) need in pediatric patients.
  • To assist primary care physicians in prompt consultation with pediatric cardiologists.

Main Methods:

  • Retrospective analysis of 60 pediatric patients (≤18 years) diagnosed with acute myocarditis between October 2011 and September 2016.
  • Data collection included demographics, clinical presentation, laboratory tests, ECG, echocardiography, treatments, and outcomes.
  • Statistical analysis to compare patients who received ECMO versus those who did not.

Main Results:

  • Fever, cough, and chest pain were the most frequent symptoms.
  • Arrhythmia, left ventricular ejection fraction (LVEF) < 60%, vomiting, weakness, and seizure were significantly more common in the ECMO group.
  • A serum troponin-I cutoff of >14.21 ng/mL indicated a need for ECMO.

Conclusions:

  • Female sex, vomiting, weakness, seizure, arrhythmia, and LVEF < 60% are potential predictors for ECMO in pediatric acute myocarditis.
  • Early recognition of these factors can facilitate prompt consultation and intervention by pediatric cardiologists.
  • Serum troponin-I levels may serve as an additional biomarker for predicting ECMO necessity.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
299
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
385